白人と日本人における2型糖尿病の発症における差異の可能性を調査する臨床試験

基本情報

NCT ID

NCT00897169

ステータス

完了

試験のフェーズ

第1相

試験タイプ

介入

目標被験者数

271

治験依頼者名

Novo Nordisk A/S

概要

This trial is conducted in Europe and Japan. The aim of this clinical trial is to investigate the possible difference in the development of type 2 diabetes in a Japanese and a Caucasian population. Healthy subjects, subjects with impaired glucose tolerance, as well as subjects with type 2 diabetes will be included in the trial. The development of type 2 diabetes across the cohort will be investigated with regard to insulin sensitivity and B-cell capacity.

対象疾患

介入

依頼者（Sponsor）